February 21, 2012

Expensive and unpleasant, but hepatitis C treatment is worth it, study shows

Research led by by Stanford Health Policy's Jeremy Goldhaber-Fiebert shows treatments for hepatitis C are cost-effective for patients with advanced disease. Their results are based on a computer model of hepatitis C.

• » AARP: Inside E Street Silent Epidemic: Hepatitis C More than 3 million Americans, most of them boomers, carry the potentially deadly virus (Video)

Read more »